Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 9/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3094658 | 0.99 | SLC6A9 (0.47) | SLC6A9KCNH2SIGMAR1OPRM1OPRD1 | |
| SCHEMBL3103988 | 0.88 | SLC6A9 (0.44) | SLC6A9KCNH2SIGMAR1OPRM1OPRD1 | |
| SCHEMBL15324458 | 0.87 | SLC6A9 (0.55) | SLC6A9ENPP2 | |
| SCHEMBL15323951 | 0.86 | SLC6A9 (0.51) | SLC6A9KCNH2SIGMAR1 | |
| Hydrochloric Acid SCHEMBL3094636 | 0.86 | SLC6A9 (0.55) | SLC6A9ENPP2 | |
| SCHEMBL15323756 | 0.85 | SLC6A9 (0.51) | SLC6A9KCNH2SIGMAR1OPRM1OPRD1 | |
| Hydrochloric Acid SCHEMBL3094665 | 0.85 | SLC6A9 (0.51) | SLC6A9KCNH2 | |
| SCHEMBL3105644 | 0.85 | SLC6A9 (0.62) | SLC6A9KCNH2SIGMAR1 | |
| Hydrochloric Acid SCHEMBL3099007 | 0.85 | SLC6A9 (0.50) | SLC6A9KCNH2SIGMAR1OPRM1OPRD1 | |
| SCHEMBL15323632 | 0.85 | SLC6A9 (0.49) | SLC6A9KCNH2SIGMAR1ENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2396296-B1 | AMINOTETRALINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY | ABBVIE DEUTSCHLAND (DE) | 2016-05-25 | — | — | EP | claimed |
| US-9067871-B2 | Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy | AbbVie Deutschland GmbH & Co. KG (DE) | 2015-06-30 | — | — | US | claimed |
| US-8563617-B2 | Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy | AbbVie Deutschland GmbH & Co. KG (DE) | 2013-10-22 | — | — | US | claimed |